The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading ->
A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading ->
WHO’s Director General Dr Tedros Adhanom Ghebreyesus on Friday issued yet another plea to leaders of rich countries to “honor their pledges” to fund COVID-19 vaccines sufficient to immunize the highest risk groups across the world. He spoke a day after South African officials raised the spectre that the world was heading towards a state […] Continue reading ->
Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading ->
Médecins Sans Frontières. As the COVID-19 pandemic threatens to derail the global response to tuberculosis (TB), Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments to accelerate testing, treatment, and prevention for TB, and called on donors to provide the financial support needed to ensure increased access to new medical tools for diagnosing and treating […] Continue reading ->
Many Geneva-based health agencies have worked together for years to improve global access to diagnostics and treatment, but the COVID-19 pandemic has necessitated much closer collaboration and speedier decision-making. This is according to experts from the WHO co-sponsored  “ACT Accelerator” medicine access partnership – including UNITAID, the Foundation for Innovative New Diagnostics (FIND), and the […] Continue reading ->